You are here

enfortumab vedotin

Here's Why Seattle Genetics Climbed 17.6% in September

Motley Fool

Mon, 10/7/19 - 11:25 pm

Seattle Genetics

clinical trials

colorectal cancer

enfortumab vedotin

urothelial cancer

Seattle Genetics makes case it can be more than Adcetris

Biopharma Dive

Mon, 09/30/19 - 12:03 pm

Seattle Genetics

clinical trials

enfortumab vedotin

ESMO: Astellas, Seattle Genetics' Keytruda combo shrinks 71% of bladder cancers

Fierce Biotech

Sat, 09/28/19 - 04:36 pm

Seattle Genetics

enfortumab vedotin

urothelial cancer

Seattle Genetics drug could provide new option for bladder cancer patients

Biopharma Dive

Mon, 06/3/19 - 11:24 am

Seattle Genetics

enfortumab vedotin

urothelial cancer

Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody

Endpoints

Thu, 03/28/19 - 10:11 am

Seattle Genetics

enfortumab vedotin